If too many cells start burning sugar instead of fat, blood sugar can dip too low between meals—this tricks the body into releasing stress hormones that block insulin, leading to high blood sugar and high insulin at the same time.
Scientific Claim
Increased whole-body glucose utilization due to aerobic glycolysis may lead to recurrent episodes of subclinical hypoglycemia, triggering counter-regulatory hormone release (e.g., cortisol, epinephrine), which antagonizes insulin action and contributes to the development of insulin resistance.
Original Statement
“Increased glucose utilization at the cell level potentially disrupts whole body glucose homeostasis... leading to episodes of subclinical hypoglycemia... triggering counter regulatory ‘stress’ hormone release... CRH oppose the insulin signal, leading to the phenotype of insulin resistance.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The claim is a theoretical cascade based on indirect evidence (e.g., PUFA increases glucose use, stress hormones cause insulin resistance). No human data directly links RBD oils to subclinical hypoglycemia or CRH spikes.
More Accurate Statement
“Increased whole-body glucose utilization due to aerobic glycolysis may be associated with recurrent episodes of subclinical hypoglycemia, triggering counter-regulatory hormone release, which could antagonize insulin action and contribute to the development of insulin resistance.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether RBD seed oil intake induces subclinical hypoglycemia and elevates counter-regulatory hormones in healthy adults.
Whether RBD seed oil intake induces subclinical hypoglycemia and elevates counter-regulatory hormones in healthy adults.
What This Would Prove
Whether RBD seed oil intake induces subclinical hypoglycemia and elevates counter-regulatory hormones in healthy adults.
Ideal Study Design
A 6-week double-blind RCT of 40 healthy adults consuming 30% of calories from RBD soy oil vs. olive oil, with continuous glucose monitoring (CGM) and hourly measurements of cortisol, epinephrine, and glucagon during fasting periods.
Limitation: Short-term; may not reflect chronic adaptation.
Prospective Cohort StudyLevel 2bWhether higher RBD oil intake predicts lower fasting glucose nadirs and elevated CRH levels over time.
Whether higher RBD oil intake predicts lower fasting glucose nadirs and elevated CRH levels over time.
What This Would Prove
Whether higher RBD oil intake predicts lower fasting glucose nadirs and elevated CRH levels over time.
Ideal Study Design
A 5-year cohort of 3,000 adults with CGM data, dietary records, and quarterly measurements of fasting cortisol and catecholamines, analyzing whether RBD oil intake predicts hypoglycemic episodes (<70 mg/dL) and CRH surges.
Limitation: CGM is expensive and not routinely collected in large cohorts.
Cross-Sectional StudyLevel 3Whether individuals with high RBD oil intake have lower fasting glucose and higher CRH levels than those with low intake.
Whether individuals with high RBD oil intake have lower fasting glucose and higher CRH levels than those with low intake.
What This Would Prove
Whether individuals with high RBD oil intake have lower fasting glucose and higher CRH levels than those with low intake.
Ideal Study Design
A cross-sectional analysis of 1,000 adults with paired dietary data, CGM-derived glucose variability metrics, and plasma cortisol/epinephrine levels, stratified by RBD oil consumption quintiles.
Limitation: Cannot establish directionality or causality.
Evidence from Studies
Supporting (1)
The study says eating certain processed oils makes your body use too much sugar in a wasteful way, which confuses your hormones and makes your body ignore insulin—leading to insulin resistance. This matches the claim exactly.